6533b831fe1ef96bd1299800
RESEARCH PRODUCT
Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)
D. Lorente EstellesSarai PalancaG. Pérez-simóNuria MancheñoO.j. Juan VidalJ. Gomez CodinaB. LaizJ. SimarroR. Murriasubject
business.industryPcr assayHematologymedicine.diseaseEGFR Tyrosine Kinase Inhibitorslaw.inventionT790MOncologylawMutation (genetic algorithm)medicineCancer researchNon small lung cancerMutation detectionLung cancerbusinessPolymerase chain reactionyear | journal | country | edition | language |
---|---|---|---|---|
2019-04-01 | Annals of Oncology |